Clinical Trial Update: Adalimumab in Severe and Acute Sciatica [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating adalimumab for severe and acute sciatica has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sciatica

Drugs mentioned

• ADALIMUMAB (ADALIMUMAB-AATY)

Snippet

Sponsor: University Hospital, Geneva | Conditions: Sciatica | Phase 2 | Status: COMPLETED